Dysbiosis in the Pathogenesis of Pediatric Inflammatory Bowel Diseases

被引:31
作者
Comito, Donatella [1 ]
Romano, Claudio [1 ]
机构
[1] Univ Messina, Pediat Dept, I-98125 Messina, Italy
关键词
D O I
10.1155/2012/687143
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Inflammatory bowel diseases (IBDs) are chronic inflammatory conditions of the gastrointestinal tract that occur in genetically susceptible individuals. Crohn's disease (CD) and ulcerative colitis (UC) are two major types of IBD. In about 20-25% of patients, disease onset is during childhood and pediatric IBD can be considered the best model for studying immunopathogentic mechanisms. The fundamentals of IBD pathogenesis are considered a defective innate immunity and bacterial killing with overaggressive adaptive immune response. A condition of "dysbiosis", with alterations of the gut microbial composition, is regarded as the basis of IBD pathogenesis. The human gastrointestinal (GI) microbial population is a complex, dynamic ecosystem and consists of up to one thousand different bacterial species. In healthy individuals, intestinalmicrobiota have a symbiotic relationship with the host organism and carry out important metabolic, "barrier,"and immune functions. Microbial dysbiosis in IBD with lack of beneficial bacteria, together with genetic predisposition, is the most relevant conditions in the pathogenesis of the pediatric IBD.
引用
收藏
页数:7
相关论文
共 61 条
[1]   Interactions Between the Host Innate Immune System and Microbes in Inflammatory Bowel Disease [J].
Abraham, Clara ;
Medzhitov, Ruslan .
GASTROENTEROLOGY, 2011, 140 (06) :1729-1737
[2]   Mechanisms of disease: The effect of infections on susceptibility to autoimmune and allergic diseases [J].
Bach, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (12) :911-920
[3]   Testing the interaction between NOD-2 status and serological response to Mycobacterium paratuberculosis in cases of inflammatory bowel disease [J].
Bernstein, Charles N. ;
Wang, Ming-Hsi ;
Sargent, Michael ;
Brant, Steven R. ;
Collins, Michael T. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (03) :968-971
[4]   Nod2: a key regulator linking microbiota to intestinal mucosal immunity [J].
Biswas, Amlan ;
Petnicki-Ocwieja, Tanja ;
Kobayashi, Koichi S. .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2012, 90 (01) :15-24
[5]   Detection and verification of Mycobacterium avium subsp paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease [J].
Bull, TJ ;
McMinn, EJ ;
Sidi-Boumedine, K ;
Skull, A ;
Durkin, D ;
Neild, P ;
Rhodes, G ;
Pickup, R ;
Hermon-Taylor, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (07) :2915-2923
[6]   POSSIBLE ROLE OF MYCOBACTERIA IN INFLAMMATORY BOWEL-DISEASE .1. AN UNCLASSIFIED MYCOBACTERIUM SPECIES ISOLATED FROM PATIENTS WITH CROHNS-DISEASE [J].
CHIODINI, RJ ;
VANKRUININGEN, HJ ;
THAYER, WR ;
MERKAL, RS ;
COUTU, JA .
DIGESTIVE DISEASES AND SCIENCES, 1984, 29 (12) :1073-1079
[7]   Microbiota-stimulated immune mechanisms to maintain gut homeostasis [J].
Chung, Hachung ;
Kasper, Dennis Lee .
CURRENT OPINION IN IMMUNOLOGY, 2010, 22 (04) :455-460
[8]   THE PHYLOGENY OF THE GENUS CLOSTRIDIUM - PROPOSAL OF 5 NEW GENERA AND 11 NEW SPECIES COMBINATIONS [J].
COLLINS, MD ;
LAWSON, PA ;
WILLEMS, A ;
CORDOBA, JJ ;
FERNANDEZGARAYZABAL, J ;
GARCIA, P ;
CAI, J ;
HIPPE, H ;
FARROW, JAE .
INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1994, 44 (04) :812-826
[9]   High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease [J].
Darfeuille-Michaud, A ;
Boudeau, J ;
Bulois, P ;
Neut, C ;
Glasser, AL ;
Barnich, N ;
Bringer, MA ;
Swidsinski, A ;
Beaugerie, L ;
Colombel, JF .
GASTROENTEROLOGY, 2004, 127 (02) :412-421
[10]  
De Hertogh Gert, 2004, MedGenMed, V6, P14